risankizumab
Phase 3- Indications
- Crohn Disease
Company intelligence / Profile preview
Investigación Biomédica para el Desarrollo de Fármacos is an experienced Mexican contract research organization and clinical trial site that conducts and manages clinical studies across all phases for pharmaceutical products, nutraceuticals, medical devices, and other health-related products. The company has supported over 50 research studies per year with more than 10 years of experience in the field. It does not develop its own drugs but provides infrastructure and expertise for external sponsors.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Investigación Biomédica para el Desarrollo de Fármacos.